Adherence to Inhaled Medications and Its Effect on Healthcare Utilization and Costs Among High-Grade Chronic Obstructive Pulmonary Disease Patients
Overview
Affiliations
Background: Adherence to inhaled medication regimens affects chronic obstructive pulmonary disease (COPD) prognosis and quality of life, and reduces the use of healthcare services, resulting in cost savings.
Objectives: To examine the effects of adherence to inhaled medication regimens on healthcare utilization and costs in high-grade COPD patients.
Methods: We performed an observational retrospective cohort study using a longitudinal data set from the Korean Health Insurance Review and Assessment Service (2008-2013) containing healthcare services' information for 50 million beneficiaries. The study population was high-grade COPD patients. "Adherent" was defined as a patient attaining a medication possession ratio (MPR) ≥ 80%. We estimated the effects of adherence on the use of intensive care units (ICUs) and emergency rooms (ERs) using a multivariate logistic regression, and estimated the effects on costs (all-cause and COPD-related) using a generalized linear model, with adjustment for patient sociodemographic characteristics, health status, and comorbidities.
Results: Of 9086 high-grade COPD patients, adherence declined from 34.7 to 22.3% over 4 years. Adherence was inversely associated with use of ICUs and costs, and this association got stronger as the adherence period lengthened. Over the 4-year period, the adherent group had a lower likelihood of using ICUs [odds ratio (OR) = 0.74, 95% confidence interval (CI) 0.60-0.91] than the non-adherent group. Similarly, the adherent group had a 10.4% lower all-cause cost (p < 0.001) and an 11.7% lower COPD-related cost (p < 0.0001) versus the non-adherent group.
Conclusions: Adherence reduces healthcare utilization and costs, so adherence is not only clinically effective but also economically efficient. However, less than one-quarter of this population remained adherent over the 4-year period, suggesting that strategies are needed to improve adherence.
Izquierdo-Condoy J, Gualpa Alvarez F, Morales-Lapo E, Arias Calvache W, Bermudez Moreira J, Quinga-Chiguano K Int J Chron Obstruct Pulmon Dis. 2025; 20:399-410.
PMID: 40008110 PMC: 11853065. DOI: 10.2147/COPD.S493992.
Zhang X, Sim Y, Tsang C, Wang J, Finch C Explor Res Clin Soc Pharm. 2024; 15:100470.
PMID: 39050144 PMC: 11267052. DOI: 10.1016/j.rcsop.2024.100470.
Bischof A, Cordier J, Vogel J, Geissler A NPJ Prim Care Respir Med. 2024; 34(1):1.
PMID: 38453930 PMC: 10920735. DOI: 10.1038/s41533-024-00361-2.
Jo Y, Han S, Lee D, Min K, Park S, Yoon H Sci Rep. 2023; 13(1):18669.
PMID: 37907619 PMC: 10618439. DOI: 10.1038/s41598-023-45835-4.
Choi J, Park Y, An T, Yoo K, Rhee C BMC Pulm Med. 2023; 23(1):378.
PMID: 37805515 PMC: 10559651. DOI: 10.1186/s12890-023-02665-4.